In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 288-14-2, name is Isoxazole, introducing its new discovery. SDS of cas: 288-14-2
Molecules containing bridged bicyclic systems, such as the (7- hetero)bicyclo[2.2.1]heptane ring system, are interesting synthetic targets because these systems are present in many molecules with biologically relevant activity. Common precursors for these sytems are the (7-hetero)nobornadienes. This review covers the different approaches used in the last ten years for the synthesis of (7-hetero)norbornadienes through Diels- Alder (D-A) cycloaddition between cyclic dienes and alkynes. The review also shows the synthetic applications of these [2.2.1]bicyclic systems as intermediates in the preparation of other relevant molecules.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 288-14-2, and how the biochemistry of the body works.Application In Synthesis of Isoxazole
Reference：
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem